Combined Treatment of Progressive Encephalitis in an X-linked Agammaglobulinemia Patient

1. Hernandez-Trujillo VP, Scalchunes C, Cunningham-Rundles C, Ochs HD, Bonilla FA, Paris K, et al. Autoimmunity and inflammation in X-linked agammaglobulinemia. J Clin Immunol. 2014;34(3):627-32.
2. Kasahara Y, Imamura M, Shin C, Shimizu H, Utsumi J, Hosokai R, et al. Fatal Progressive Meningoencephalitis Diagnosed in Two Members of a Family With X-Linked Agammaglobulinemia. Front. Pediatr. 2020;8:579.
3. Teramoto T, Kaneko H, Funato M, Sawa H, Nagashima K, Hirose Y, et al. Progressive multifocal leukoencephalopathy in a patient with X-linked agammaglobulinemia. Scand J Infect Dis. 2003;35(11-12):909-10.
4. Gall T, Hawley J, May Y. Progressive neurodegeneration in X-linked agammaglobulinemia (meeting abstract). Neurology 2019;95(15 Suppl):P1.7-005.
5. Tuzankina I, Kobeleva Y, Kiseleva N, Bolkov M, Reuter G, Maródi L. Cytotoxic T Lymphocytes Mediate Neuronal Injury in Patients With X-linked Agammaglobulinemia and Progressive Neurodegenerative Disease. Allergy. 2011;66:1617-8.
6. Domingo A, Schmidt TG, Barcelon E, Lukban M, Westenberger A, Klein C. X-linked agammaglobulinemia with hearing impairment, dystonia-parkinsonism, and progressive neurodegeneration. J Neurol. 2014;261:2225-7.
7. Sag AT, Saka E, Ozgur TT, Sanal O, Ayvaz DC, Elibol B, et al. Progressive Neurodegenerative Syndrome in a Patient With X-linked Agammaglobulinemia Receiving Intravenous Immunoglobulin Therapy. Cogn Behav Neurol. 2014;27:155-9.
8. Mohammadzadeh I, Yeganeh M, Khaledi M, Salehiomran MR, Aghamohammadi A, Rezaei N. Debilitating Progressive Encephalitis in a Patient With BTK Deficiency. Acta Microbiol Immunol Hung. 2012;59:335-42.
9. Saini AG, Radotra BD, Bhattarai D, Rawat A, Bhatia V. X-Linked Agammaglobulinemia With Chronic Meningoencephalitis: A Diagnostic Challenge. Indian Pediatr. 2021.15;58(2):169-173.
10. Frémond ML, Pérot P, Muth E, Cros G, Dumarest M, Mahlaoui N, et al. Next-Generation Sequencing for Diagnosis and Tailored Therapy: A Case Report of Astrovirus-Associated Progressive Encephalitis. J Pediatric Infect Dis Soc. 2015;4:e53-7.
11. Wilson MR, Suan D, Duggins A, Schubert RD, Khan LM, Sample HA, et al. A Novel Cause of Chronic Viral Meningoencephalitis: Cache Valley Virus. Ann Neurol. 2017;82(6):105-114.
12. Nakano A, Yamasaki R, Miyazaki S, Horiuchi N, Kunishige M, Mitsui T. Beneficial effect of steroid pulse therapy on acute viral encephalitis. Eur Neurol. 2003;50(4):225-9.
13. Gofshteyn J, Cárdenas AM, Bearden D. Treatment of Chronic Enterovirus Encephalitis With Fluoxetine in a Patient With X-Linked Agammaglobulinemia. Pediatr Neurol. 2016;64:94-98.
14. Chetty K, Cheng I, Kaliakatsos M, Gonzalez-Granado LI, Klapsa D, Martin J, et al. Case report: Novel treatment regimen for enterovirus encephalitis in SCID. Front Immunol. 2022;13:930031.
15. Sham L, Bitnun A, Branson H, Hazrati LN, Dell SD, Yeung RSM, et al. Treatment of rituximab-associated chronic CNS enterovirus using IVIg and fluoxetine. Neurology. 2019;92(19):916-18.
16. Hargest V, Sharp B, Livingston B, Cortez V, Schultz-Cherry S. Astrovirus Replication Is Inhibited by Nitazoxanide In Vitro and In Vivo. J Virol. 2020;94(5):e01706-19
17. Shakya A, Bhat HR, Ghosh SK. Update on Nitazoxanide: A Multifunctional Chemotherapeutic Agent. Curr Drug Discov Technol. 2018;15(3):201-13
18. Sukumaran S, Marzan K, Shaham B, Church JA. A Child With X-Linked Agammaglobulinemia and Enthesitis-Related Arthritis. Int J Rheumatol. 2011;2011:175973.
19. Han SP, Lin YF, Weng HY, Tsai SF, Fu LS. A Novel BTK Gene Mutation in a Child with Atypical X-Linked Agammaglobulinemia and Recurrent Hemophagocytosis: A Case Report. Front Immunol. 2019;10(2):1953.
20. Rivas-Larrauri F, Aguilar-Zanela L, Castro-Oteo P, Rosales-Hernandez LA, Otero-Mendoza F, López-Herrera G, et al. Kawasaki disease and immunodeficiencies in children: case reports and literature review. Rheumatol Int. 2019;39:1829-1838.
21. Barmettler S, Otani IM, Minhas J, Abraham RS, Chang Y, Dorsey MJ, Ballas ZK, et al. Gastrointestinal Manifestations in X-linked Agammaglobulinemia. J Clin Immunol. 2017;37(3):287-94.
22. Lavrador V, Correia F, Sampaio R, Candido C, Sameiro-Faria M, Marques L, Mota C. Membranoproliferative Glomerulonephritis and X-Linked Agammaglobulinemia: An Uncommon Association. Case Rep Pediatr. 2014;2014:480947.
23. Tan Q, Ren FL, Wang H. Pyoderma Gangrenosum in a Patient with X-Linked Agammaglobulinemia. Ann Dermatol. 2017;29(4):476-8.
24. Mao L, Kitani A, Hiejima E, Montgomery-Recht K, Zhou W, Fuss I, Wiestner A, Strober W. Bruton tyrosine kinase deficiency augments NLRP3 inflammasome activation and causes IL-1β-mediated colitis. J Clin Invest. 2020;130(21):1793-1807.
25. González-Serrano ME, Estrada-García I, Mogica-Martínez D, González-Garay A, López-Herrera G, Berrón-Ruiz L, et al. Increased proinflammatory cytokine production after lipopolysaccharide stimulation in patients with X-linked agammaglobulinemia. J Clin Immunol. 2012;32(15):967-74.
26. Ray S, Kathuria H, Chakravarty K, Rawat A, Takkar A, Mehta S, et al. Seronegative panencephalitis complicated by viral encephalomyelitis in a case of Good's syndrome - a neuropathological report. Int J Neurosci. 2020:1-6.

留言 (0)

沒有登入
gif